epitope

E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.

After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.

The epitope on the virus is a target for the immune response.

Researchers are studying the structure of the epitope to develop a vaccine.

Antibodies bind to specific epitopes on antigens to neutralize them.

Understanding the epitope-antibody interaction is crucial in immunology.

The epitope recognition by T cells triggers an immune response.

Epitope mapping helps identify regions of proteins that are recognized by antibodies.

Vaccines are designed to stimulate the immune system to recognize specific epitopes.

The mutation in the epitope can affect the effectiveness of a vaccine.

Epitope prediction tools are used to identify potential vaccine targets.

Epitope variability can pose challenges in developing vaccines against certain pathogens.